These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 37974628)
1. Small-Molecule Activation of Protein Phosphatase 2A Counters Bleomycin-Induced Fibrosis in Mice. Pillai M; Lafortune P; Dabo A; Yu H; Park SS; Taluru H; Ahmed H; Bobrow D; Sattar Z; Jundi B; Reece J; Ortega RR; Soto B; Yewedalsew S; Foronjy R; Wyman A; Geraghty P; Ohlmeyer M ACS Pharmacol Transl Sci; 2023 Nov; 6(11):1659-1672. PubMed ID: 37974628 [TBL] [Abstract][Full Text] [Related]
2. Evaluating Novel Protein Phosphatase 2A Activators as Therapeutics for Emphysema. Soto B; Ahmed H; Pillai M; Park SS; Ploszaj M; Reece J; Taluru H; Bobrow D; Yu H; Lafortune P; Jundi B; Costanzo L; Dabo AJ; Foronjy RF; Mueller C; Ohlmeyer M; Geraghty P Am J Respir Cell Mol Biol; 2023 Nov; 69(5):533-544. PubMed ID: 37526463 [TBL] [Abstract][Full Text] [Related]
3. PP2A activation overcomes leptomeningeal dissemination in group 3 medulloblastoma. Nazam N; Erwin MH; Julson JR; Quinn CH; Beierle AM; Bownes LV; Stewart JE; Kang KD; Butey S; Mroczek-Musulman E; Ohlmeyer M; Beierle EA J Biol Chem; 2024 Nov; 300(11):107892. PubMed ID: 39419284 [TBL] [Abstract][Full Text] [Related]
4. Blocking protein phosphatase 2A with a peptide protects mice against bleomycin-induced pulmonary fibrosis. Yu J; Deng Y; Han M Exp Lung Res; 2020 Sep; 46(7):234-242. PubMed ID: 32584210 [TBL] [Abstract][Full Text] [Related]
5. [Effects of antisense oligonucleotide to nuclear factor-kappaB on the development of bleomycin-induced pulmonary fibrosis and IL-4 expression therein: experiment with mice]. Zhang XY; Zhou Y; Liu WQ; Zhao L; Li SQ Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(3):195-9. PubMed ID: 17425852 [TBL] [Abstract][Full Text] [Related]
6. The XPO1 inhibitor selinexor ameliorates bleomycin-induced pulmonary fibrosis in mice via GBP5/NLRP3 inflammasome signaling. Zhang J; Zhang Y; Chen Q; Qi Y; Zhang X Int Immunopharmacol; 2024 Mar; 130():111734. PubMed ID: 38422768 [TBL] [Abstract][Full Text] [Related]
7. BTB and CNC homology 1 inhibition ameliorates fibrosis and inflammation via blocking ERK pathway in pulmonary fibrosis. Liu Y; Wang Y; Lu F; Wang L; Miao L; Wang X Exp Lung Res; 2021; 47(2):67-77. PubMed ID: 33238752 [TBL] [Abstract][Full Text] [Related]
8. The IL-33:ST2 axis is unlikely to play a central fibrogenic role in idiopathic pulmonary fibrosis. Stephenson KE; Porte J; Kelly A; Wallace WA; Huntington CE; Overed-Sayer CL; Cohen ES; Jenkins RG; John AE Respir Res; 2023 Mar; 24(1):89. PubMed ID: 36949463 [TBL] [Abstract][Full Text] [Related]
9. Histopathological Correlations between Mediastinal Fat-Associated Lymphoid Clusters and the Development of Lung Inflammation and Fibrosis following Bleomycin Administration in Mice. Elewa YHA; Ichii O; Takada K; Nakamura T; Masum MA; Kon Y Front Immunol; 2018; 9():271. PubMed ID: 29497425 [TBL] [Abstract][Full Text] [Related]
10. Pulmonary fibrosis model of mice induced by different administration methods of bleomycin. Gul A; Yang F; Xie C; Du W; Mohammadtursun N; Wang B; Le J; Dong J BMC Pulm Med; 2023 Mar; 23(1):91. PubMed ID: 36944966 [TBL] [Abstract][Full Text] [Related]
11. Effect of glycosides based standardized fenugreek seed extract in bleomycin-induced pulmonary fibrosis in rats: Decisive role of Bax, Nrf2, NF-κB, Muc5ac, TNF-α and IL-1β. Kandhare AD; Bodhankar SL; Mohan V; Thakurdesai PA Chem Biol Interact; 2015 Jul; 237():151-65. PubMed ID: 26093215 [TBL] [Abstract][Full Text] [Related]
12. Necrostatin-1 Alleviates Bleomycin-Induced Pulmonary Fibrosis and Extracellular Matrix Expression in Interstitial Pulmonary Fibrosis. Mou F; Mou C Med Sci Monit; 2020 Feb; 26():e919739. PubMed ID: 32019905 [TBL] [Abstract][Full Text] [Related]
13. Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway. Saito S; Zhuang Y; Shan B; Danchuk S; Luo F; Korfei M; Guenther A; Lasky JA PLoS One; 2017; 12(10):e0186615. PubMed ID: 29045477 [TBL] [Abstract][Full Text] [Related]
14. Low-dose administration of bleomycin leads to early alterations in lung mechanics. Headley L; Bi W; Wilson C; Collum SD; Chavez M; Darwiche T; Mertens TCJ; Hernandez AM; Siddiqui SR; Rosenbaum S; Johnston RA; Karmouty-Quintana H Exp Physiol; 2018 Dec; 103(12):1692-1703. PubMed ID: 30260066 [TBL] [Abstract][Full Text] [Related]
15. The Effects of Protein Phosphatase 2A Activation with Novel Tricyclic Sulfonamides on Hepatoblastoma. Bownes LV; Julson JR; Quinn CH; Hutchins SC; Erwin MH; Markert HR; Stewart JE; Mroczek-Musulman E; Aye J; Yoon KJ; Ohlmeyer M; Beierle EA J Pediatr Surg; 2023 Jun; 58(6):1145-1154. PubMed ID: 36907775 [TBL] [Abstract][Full Text] [Related]
16. Sunitinib, a Small-Molecule Kinase Inhibitor, Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice. Huang X; Wang W; Yuan H; Sun J; Li L; Wu X; Luo J; Gu Y Tohoku J Exp Med; 2016 Aug; 239(4):251-61. PubMed ID: 27439438 [TBL] [Abstract][Full Text] [Related]
17. Pivotal role of connective tissue growth factor in lung fibrosis: MAPK-dependent transcriptional activation of type I collagen. Ponticos M; Holmes AM; Shi-wen X; Leoni P; Khan K; Rajkumar VS; Hoyles RK; Bou-Gharios G; Black CM; Denton CP; Abraham DJ; Leask A; Lindahl GE Arthritis Rheum; 2009 Jul; 60(7):2142-55. PubMed ID: 19565505 [TBL] [Abstract][Full Text] [Related]
18. Bleomycin Induces Drug Efflux in Lungs. A Pitfall for Pharmacological Studies of Pulmonary Fibrosis. Park JK; Coffey NJ; Bodine SP; Zawatsky CN; Jay L; Gahl WA; Kunos G; Gochuico BR; Malicdan MCV; Cinar R Am J Respir Cell Mol Biol; 2020 Feb; 62(2):178-190. PubMed ID: 31419911 [TBL] [Abstract][Full Text] [Related]
19. CD148 Deficiency in Fibroblasts Promotes the Development of Pulmonary Fibrosis. Tsoyi K; Liang X; De Rossi G; Ryter SW; Xiong K; Chu SG; Liu X; Ith B; Celada LJ; Romero F; Robertson MJ; Esposito AJ; Poli S; El-Chemaly S; Perrella MA; Shi Y; Whiteford J; Rosas IO Am J Respir Crit Care Med; 2021 Aug; 204(3):312-325. PubMed ID: 33784491 [No Abstract] [Full Text] [Related]
20. Ajulemic acid exerts potent anti-fibrotic effect during the fibrogenic phase of bleomycin lung. Lucattelli M; Fineschi S; Selvi E; Garcia Gonzalez E; Bartalesi B; De Cunto G; Lorenzini S; Galeazzi M; Lungarella G Respir Res; 2016 May; 17(1):49. PubMed ID: 27153807 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]